SCLX
Scilex Holding Company
NASDAQ · USHealthcareDrug Manufacturers - General
$7.64-9.48%
Price as of Jul 20, 2026
SCLX valuation
Scilex Holding Company valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 1.86x
- P/E 2026E
- 2.53x
- P/E 2027E
- 1.20x
- P/E 2028E
- 0.83x
- P/S forward
- 0.16x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.26x
- Price / sales
- 1.92x
- Price / cash flow
- -17.51x
Enterprise value
- Enterprise value
- $163.0M
- EV / sales
- 4.81x
- EV / EBITDA
- -0.44x
- EV / EBIT
- -0.59x
- Market cap
- $64.9M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.